Article Text
Miscellaneous
Intrapleural streptokinase does not improve outcomes in empyema
Statistics from Altmetric.com
Intrapleural fibrinolytic agents have been advocated in the management of pleural infection in many respiratory society guidelines. However, the evidence base for this recommendation stems from case series and small trials which do not have adequate statistical power.
The MIST1 study was a double blind, randomised, controlled trial with 454 patients enrolled in …